Clinical Trial Update: Implementing LISA Surfactant in Nigeria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on implementing Less Invasive Surfactant Administration (LISA) for neonatal respiratory distress syndrome in Nigeria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• LISA Surfactant

Snippet

Sponsor: Indiana University | Conditions: Respiratory Distress Syndrome, Neonatal Death | Phase 4 | Status: COMPLETED